VIM and neoplasm: For each of the three primary xenograft lines, IHC with a human-specific vimentin antibody demonstrated dense tumor growth within the injected striatum and infiltrative growth along myelinated fiber tracts (the corpus callosum and the striatopallidal fibers or “pencil fibers”) in the contralateral hemisphere (Fig 2).